Group One Trading
ANIK icon

Group One Trading’s Anika Therapeutics ANIK Stock Holding History

Group One Trading’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.93K Buy
+200
New +$2.96K ﹤0.01% 6919
2020
Q1 		– Sell
-5,196
Closed -$210K – 5201
2019
Q4 		$269K Sell
5,196
-2,904
-36% -$169K ﹤0.01% 2947
2019
Q3 		$445K Buy
8,100
+6,993
+632% +$359K ﹤0.01% 2434
2019
Q2 		$45K Sell
1,107
-8,388
-88% -$306K ﹤0.01% 3820
2019
Q1 		$287K Buy
9,495
+5,495
+137% +$188K ﹤0.01% 2411
2018
Q4 		$134K Buy
+4,000
New +$144K ﹤0.01% 2978
2018
Q1 		– Sell
-400
Closed -$22K – 4792
2017
Q4 		$22K Sell
400
-2,000
-83% -$111K ﹤0.01% 4110
2017
Q3 		$139K Buy
2,400
+1,200
+100% +$62.7K ﹤0.01% 3010
2017
Q2 		$59K Buy
+1,200
New +$55.3K ﹤0.01% 3416
2016
Q1 		– Sell
-10,743
Closed -$410K – 4528
2015
Q4 		$410K Buy
10,743
+1,790
+20% +$68.5K ﹤0.01% 1980
2015
Q3 		$285K Sell
8,953
-6,283
-41% -$219K ﹤0.01% 2236
2015
Q2 		$503K Buy
15,236
+5,714
+60% +$204K 0.01% 1777
2015
Q1 		$392K Buy
9,522
+8,126
+582% +$329K 0.01% 1812
2014
Q4 		$57K Buy
1,396
+395
+39% +$15.4K ﹤0.01% 3279
2014
Q3 		$37K Sell
1,001
-1,394
-58% -$60.2K ﹤0.01% 3742
2014
Q2 		$111K Sell
2,395
-8,957
-79% -$398K ﹤0.01% 2883
2014
Q1 		$467K Buy
11,352
+3,021
+36% +$112K 0.01% 1686
2013
Q4 		$318K Buy
+8,331
New +$257K ﹤0.01% 2023

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
CM
Capital Management Glen Allen, Virginia $666M AUM 17.17% 1-Year Est. Return

Group One Trading's ANIK Position: Q2 2026 in Review

Group One Trading opened a new position in Anika Therapeutics (ANIK) in Q2 2026: 200 shares worth $2.93K. The stake represents ﹤0.01% of the portfolio and ranks #6919 among its holdings. This is a return to the name: Group One Trading previously reported a position in ANIK as recently as Q4 2019.

Group One Trading first reported a position in ANIK in Q4 2013 and has held it in 18 quarters since. The position peaked at $503K in Q2 2015. 133 funds tracked by Wall St. Rank hold ANIK as of Q2 2026.

  • Group One Trading held 200 shares of Anika Therapeutics worth $2.93K as of Q2 2026.
  • Anika Therapeutics was a new Group One Trading position in Q2 2026.
  • Anika Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #6919 holding.
  • Group One Trading first reported a position in Anika Therapeutics in Q4 2013 and has held it in 18 quarters since.
  • Group One Trading's Anika Therapeutics position peaked at $503K in Q2 2015.
  • 133 funds tracked by Wall St. Rank held Anika Therapeutics as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.